Spectrum Pharmaceuticals Investor Relations Material
Latest events
Q4 2022
Spectrum Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Spectrum Pharmaceuticals Inc
Access all reports
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing and commercializing oncology and hematology drug products. It operates through the following segments: North American Sales, International Sales, and Research and Development. The company's product candidates include FUSILEV , ZEVALIN, VALSTAR, GAMMATOPHOS, KYTRIL, SUTENT, and VORAXAZE. It offers FUSILEV (levoleucovorin) oral granules, ZEVALIN (ibritumomab tiuxetan) for injection for the treatment of patients with indolent non-Hodgkin's lymphoma monitored by x-ray prior to treatment and during treatment cycle number one; cancer of the ovary or fallopian tube. Spectrum Pharmaceuticals, Inc. is based in Henderson, Nevada.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SPPI
Country
🇺🇸 United States